Books
in black and white
Main menu
Share a book About us Home
Books
Biology Business Chemistry Computers Culture Economics Fiction Games Guide History Management Mathematical Medicine Mental Fitnes Physics Psychology Scince Sport Technics
Ads

biopharmaceuticals biochemistry and biotecnology - Walsh G.

Walsh G. biopharmaceuticals biochemistry and biotecnology - John Wiley & Sons, 2003. - 572 p.
ISBN 0-470-84327-6
Download (direct link): biochemistryandbiotechnology2003.pdf
Previous << 1 .. 184 185 186 187 188 189 < 190 > 191 192 193 194 195 196 .. 292 >> Next

HORMONES OF THERAPEUTIC INTEREST 349
Lacy, P. (1995). Treating diabetes with transplanted cells. Sci. Am. July, 40-45.
Maassen, J. & Ouwens, D. (1997). Mechanism of insulin action. Frontiers Hormone Res. 22, 201-221.
Patton, J. et al. (1999). Inhaled insulin. Adv. Drug Delivery Rev. 35, 235-247.
Rhodes, C. & White, M. (2002). Molecular insights into insulin action and secretion. Eur. J. Clin. Invest. 32, 3-13. Secchi, A. et al. (1997). Pancreas and Islet transplantation current progress, problems and perspectives. Hormone Metab. Res. 29(1), 1-8.
Selam, J. (1997). Management of diabetes with glucose sensors and implantable insulin pumps from the dream of the 60s to the realities of the 90s. ASAIO J. 43(3), 137-142.
Smith, R. et al. (1997). Insulin internalization and other signalling pathways in the pleiotropic effects of insulin. Int. Rev.
Cytol. Surv. Cell Biol. 173, 243-280.
Stralfors, P. (1997). Insulin 2nd messengers. Bioessays 19(4), 327-335.
Vajo, Z. et al. (2001). Recombinant DNA technology in the treatment of diabetes: insulin analogues. Endocr. Rev. 22(5), 706-717.
Growth hormone
Artini, P. et al. (1996). Growth hormone co-treatment with gonadotrophins in ovulation induction. J. Endocrinol. Invest. 19(11), 763-779.
Carter, C. et al. (2002). A critical analysis of the role of growth hormone and IGF-1 in aging and lifespan. Trends Genet. 18(6), 295-301.
Chantalat, L., Jones, N. D., Korber, F. et al. (1995). The crystal structure of wild-type growth hormone at 2.5 A resolution. Protein Peptide Lett. 2, 333.
De Vos, A. et al. (1992). Human growth hormone and extracellular domain of its receptor; crystal structure of the complex. Science 255, 306-312.
Gibson, F. & Hinds, C. (1997). Growth hormone and insulin-like growth factors in critical illness. Intens. Care Med. 23(4), 369-378.
Hathaway, D. (2002). Growth hormone: challenges and opportunities for the biotechnology sector. J. Anti-aging Med. 5(1), 57-62.
Neely, E. (1994). Use and abuse of human growth hormone. Ann. Review Med. 45, 407-420.
Piwien-Pilipuk, G. et al. (2002). Growth hormone signal transduction. J. Pediat. Endocrinol. Metab. 15(6), 771-786. Sharara, F. & Giudice, K. (1997). Role of growth hormone in ovarian physiology and onset of puberty. J. Soc. Gynaecol. Invest. 4(1), 2-7.
Simpson, H. et al. (2002). Growth hormone replacement therapy for adults: into the new millennium. Growth Hormone IGF Res. 12(1), 1-33.
Gonadotrophins and TSH
Barbieri, R. (1992). Clinical applications of GnRH and its analogues. Trends Endocrinol. Metab. 3(1), 30-34.
Bernard, D. et al. (2002). Minireview: inhibin binding protein, b-glycan and the continuing search for the inhibin receptor. Mol. Endocrinol. 16(2), 207-212.
Cho, B. (2002). Clinical applications of TSH receptor antibodies in thyroid diseases. J. Korean Med. Sci. 17(3), 293-301.
Conn, P. & Crowley, W. (1994). Gonadotropin-releasing hormone and its analogues. Ann. Rev. Med. 45, 391-405.
Dardenne, M. & Savino, W. (1996). Interdependence of the endocrine and immune systems. Adv. Neuroimmunol. 6(4), 297-307.
De Jong, F. (1988). Inhibin. Physiol. Rev. 68, 555-595.
De Koning, W. et al. (1994). Recombinant reproduction. Bio/Technology 12, 988-992.
Depaolo, L. (1997). Inhibins, activins and follistatins the saga continues. Proc. Soc. Exp. Biol. Med. 214(4), 328-339.
Fauser, B. & Vanheusden, A. (1997). Manipulation of human ovarian function physiological concepts and clinical consequences. Endocr. Rev. 18(1), 71-106.
Gore, A. & Roberts, J. (1997). Regulation of gonadotrophin-releasing hormone gene expression in vivo and in vitro. Frontiers Neuroendocrinol. 18(2), 209-245.
Greenberg, N. et al. (1991). Expression of biologically active heterodimeric bovine follicle-stimulating hormone in milk of transgenic mice. Proc. Natl Acad. Sci. USA 88, 8327-8331.
Hayden, C. et. al. (1999). Recombinant gonadotrophins. Br. J. Obstet. Gynaecol. 106(3), 188-196.
Hillier, S. (1994). Current concepts of the role of follicle stimulating hormone and luteinizing hormone in folliculogenesis. Hum. Reprod. 9(2), 188-191.
Jones, R. et al. (2002). Potential roles for endometrial inhibins, activins and follistatin during human embryo implantation and early pregnancy. Trends Endocrinol. Metab. 13(4), 144-150.
Macklon, N. & Fauser, B. (2001). Follicle stimulating hormone and advanced follicle development in the human. Arch. Med. Res. 32(6), 595-600.
350 BIOPHARMACEUTICALS
Matzuk, M. et al. (1992). a-Inhibin is a tumor-suppressor gene with gonadal specificity in mice. Nature 360, 313-319.
McCann, S. et al. (2001). Control of gonadotrophin secretion by follicule stimulating hormone-releasing factor, luteinizing hormone-releasing hormone and leptin. Arch. Med. Res. 32(6), 476-485.
Rao, C. & Sanfilippo, J. (1997). New understanding in the biochemistry of implantation potential direct roles of luteinizing hormone and human chorionic gonadotropin. Endocrinologist 7(2), 107-111.
Previous << 1 .. 184 185 186 187 188 189 < 190 > 191 192 193 194 195 196 .. 292 >> Next